Positive trial welcomed but early diagnosis is considered essential

“This landmark study demonstrates that early identification and early treatment with donanemab can significantly slow the progression of Alzheimer’s disease," said Tori Brown, the general manager of Eli Lilly Australia and New Zealand. …